/

Other

/

Talecris Biotherapeutics, Inc.

Talecris Biotherapeutics, Inc.

Talecris Biotherapeutics, Inc.

Verified Nov 2026

Other

·

United States flag

Durham, North Carolina

·

Since 2005

Talecris Biotherapeutics, Inc., headquartered in Durham, North Carolina, was founded in 2005 as a global biopharmaceutical company producing plasma-derived protein therapies for rare and chronic conditions. With 1,000–5,000 employees and estimated revenue of $100–250 million, the company specialized in immunology, pulmonology, neurology, and hemostasis treatments including Gamunex and Prolastin. Grifols acquired Talecris in June 2011.

Talecris Biotherapeutics, Inc.

Verified Nov 2026

AT A GLANCE

Founded

2005

Headquarters

United States flag

Durham, North Carolina

Employees

1,000-5,000

Ownership

Talecris Biotherapeutics, Inc. at a glance

Revenue

$100-250M

Est. band

Employees

1,000-5,000

Founded

2005

Headquarters

Durham, North Carolina

Industries

Automotive

Electric Vehicles

Overview

Talecris Biotherapeutics, Inc., headquartered in Durham, North Carolina, was founded in 2005 as a global biopharmaceutical company producing plasma-derived protein therapies for rare and chronic conditions. With 1,000–5,000 employees and estimated revenue of $100–250 million, the company specialized in immunology, pulmonology, neurology, and hemostasis treatments including Gamunex and Prolastin. Grifols acquired Talecris in June 2011.

At a glance

Attribute

Detail

Founded

2005

Headquarters

Durham, North Carolina

Employees

1,000-5,000

Revenue

$100-250M (estimated)

What Talecris Biotherapeutics, Inc. makes

Talecris produced immunoglobulins, alpha-1 proteinase inhibitors, albumin products for blood volume replacement, and hyperimmune globulins for critical care.

Latest developments

Facilities

Talecris Biotherapeutics, Inc. is headquartered in Durham, North Carolina. Public sources also reference these locations:

Company details

Grifols' acquisition of Talecris in 2011 expanded the buyer's position in the global plasma protein therapeutics market. Talecris Biotherapeutics, Inc. was founded in 2005, has an estimated 1,000-5,000 employees, and is headquartered in Durham, North Carolina.

Frequently asked questions

What does Talecris Biotherapeutics, Inc. do?

Talecris Biotherapeutics, Inc., headquartered in Durham, North Carolina, was founded in 2005 as a global biopharmaceutical company producing plasma-derived protein therapies for rare and chronic conditions. With 1,000–5,000 employees and estimated revenue of $100–250 million, the company specialized in immunology, pulmonology, neurology, and hemostasis treatments including Gamunex and Prolastin. Grifols acquired Talecris in June 2011.

Where is Talecris Biotherapeutics, Inc. headquartered?

Talecris Biotherapeutics, Inc. is headquartered in Durham, North Carolina (79 TW Alexander Dr, Durham, North Carolina, 27709).

When was Talecris Biotherapeutics, Inc. founded?

Talecris Biotherapeutics, Inc. was founded in 2005.

How big is Talecris Biotherapeutics, Inc.?

Talecris Biotherapeutics, Inc. has an estimated 1,000-5,000 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Durham, North Carolina (HQ)Headquarters · United States
Durham, North Carolina (HQ)79 TW Alexander Dr, Durham, North Carolina, 27709, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.